SEC Form 4 · accession 0001127602-17-024821
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Mackay
Director
Period of report
Aug 1, 2017
Accepted (ET)
Aug 3, 2017 · 8:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2017 | A | 2,175 | $0.00 | A | 2,175 | D | |
| Common Stock | Aug 1, 2017 | A | 607 | $0.00 | A | 2,782 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 2,175 unvested restricted stock units that vest on 8/1/2018.
- F2This grant was made in lieu of cash for director service fees for the term commencing July 1, 2017. The restricted stock units vest on 8/1/2018.